Table Of Contents

1. Market Context & Strategic Relevance

 1.1 Opening Context (Why the market matters)

 1.1.1 Why This Market Is Gaining Strategic Attention

     1.1.2 Business Decisions This Report Supports

 1.2 Scope

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size By Indication

  2.3.2 Market Size By Route of Administration

  2.3.3 Market Size By Distribution Channel

 2.3.4 Market Size By End User

 2.4 Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Biologic Raw Material Suppliers, Cell Culture Media Providers & API Manufacturers

3.4.2 Biopharmaceutical Manufacturers, Fill-Finish Facilities & Quality Assurance Providers

3.4.3 Specialty Pharmaceutical Distributors, Cold Chain Logistics Providers & Specialty Pharmacy Networks

3.4.4 Hospitals, Dermatology Clinics, Gastroenterology Clinics, Specialty Pharmacies & Patients

 3.5 Industry Life Cycle Assessment

4. Statistical Insights & Trends Reporting

 4.1 Prescription & Treatment Adoption Analysis

4.1.1 Tremfya Adoption by Indication & End User

4.1.2 Prescription Trends Across Autoimmune Diseases

4.1.3 Biologic Therapy Utilization Analysis

4.1.4 Patient Switching & Treatment Persistence Trends

4.1.5 Regional Prescription Volume Analysis

4.2 Clinical & Technology Insights

4.2.1 IL-23 Inhibitor Clinical Performance Trends

4.2.2 Long-Term Safety & Efficacy Analysis

4.2.3 Biologic Formulation & Delivery Innovations

4.2.4 Real-World Evidence & Patient Outcome Trends

4.2.5 Pipeline Expansion & Label Extension Analysis

4.3 Commercial & Industry Intelligence

4.3.1 Drug Pricing & Reimbursement Trends

4.3.2 Competitive Benchmarking of IL-23 Inhibitors

4.3.3 Biosimilar Development & Patent Landscape Analysis

4.3.4 Strategic Collaborations & Licensing Activities

4.3.5 Distribution Channel & Specialty Pharmacy Trends

4.4 Future Outlook & Emerging Opportunities

4.4.1 Expansion into New Autoimmune Disease Indications

4.4.2 Growth in Biologic Therapy Adoption

4.4.3 Personalized Immunology Treatment Trends

4.4.4 Future Roadmap for Next-Generation IL-23 Therapies

5. Tremfya Market Segmental Analysis & Forecast, By Indication, 2022–2035, Value (USD Billion)

5.1 Introduction

 5.2 Plaque Psoriasis

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022–2035

 5.3 Inflammatory Bowel Disease

 5.4 Psoriatic Arthritis

 5.5 Others

6. Tremfya Market Segmental Analysis & Forecast, By Route of Administration, 2022–2035, Value (USD Billion)

    6.1 Introduction

 6.2 Subcutaneous

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022–2035

 6.3 Intravenous

7. Tremfya Market Segmental Analysis & Forecast, By Distribution Channel, 2022–2035, Value (USD Billion)

    7.1 Introduction

 7.2 Specialty Pharmacies

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022–2035

 7.3 Hospital Pharmacies

 7.4 Others

8. Tremfya Market Segmental Analysis & Forecast, By End User, 2022–2035, Value (USD Billion)

    8.1 Introduction

 8.2 Dermatology Clinics

  8.2.1 Key Trends

  8.2.2 Market Size & Forecast, 2022–2035

 8.3 Gastroenterology Clinics

 8.4 Others

9. Tremfya Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)

9.1 Introduction

9.2 North America

 9.2.1 Key Trends

 9.2.2 Tremfya Market Size & Forecast, By Indication, 2022–2035

 9.2.3 Tremfya Market Size & Forecast, By Route of Administration, 2022–2035

 9.2.4 Tremfya Market Size & Forecast, By Distribution Channel, 2022–2035

 9.2.5 Tremfya Market Size & Forecast, By End User, 2022–2035

 9.2.6 Tremfya Market Size & Forecast, By Country, 2022–2035

  9.2.6.1 USA

  9.2.6.2 Canada

9.3 Europe

 9.3.1 Key Trends

 9.3.2 Tremfya Market Size & Forecast, By Indication, 2022–2035

 9.3.3 Tremfya Market Size & Forecast, By Route of Administration, 2022–2035

 9.3.4 Tremfya Market Size & Forecast, By Distribution Channel, 2022–2035

 9.3.5 Tremfya Market Size & Forecast, By End User, 2022–2035

 9.3.6 Tremfya Market Size & Forecast, By Country, 2022–2035

  9.3.6.1 Germany

  9.3.6.2 UK

  9.3.6.3 France

  9.3.6.4 Italy

  9.3.6.5 Spain

  9.3.6.6 Russia

  9.3.6.7 Poland

  9.3.6.8 Rest of Europe

9.4 Asia-Pacific

 9.4.1 Key Trends

 9.4.2 Tremfya Market Size & Forecast, By Indication, 2022–2035

 9.4.3 Tremfya Market Size & Forecast, By Route of Administration, 2022–2035

 9.4.4 Tremfya Market Size & Forecast, By Distribution Channel, 2022–2035

 9.4.5 Tremfya Market Size & Forecast, By End User, 2022–2035

 9.4.6 Tremfya Market Size & Forecast, By Country, 2022–2035

  9.4.6.1 China

  9.4.6.2 India

  9.4.6.3 Japan

  9.4.6.4 South Korea

  9.4.6.5 Australia

  9.4.6.6 ASEAN Countries

  9.4.6.7 Rest of Asia-Pacific

9.5 Latin America

 9.5.1 Key Trends

 9.5.2 Tremfya Market Size & Forecast, By Indication, 2022–2035

 9.5.3 Tremfya Market Size & Forecast, By Route of Administration, 2022–2035

 9.5.4 Tremfya Market Size & Forecast, By Distribution Channel, 2022–2035

 9.5.5 Tremfya Market Size & Forecast, By End User, 2022–2035

 9.5.6 Tremfya Market Size & Forecast, By Country, 2022–2035

  9.5.6.1 Brazil

  9.5.6.2 Argentina

  9.5.6.3 Mexico

  9.5.6.4 Colombia

  9.5.6.5 Rest of Latin America

9.6 Middle East & Africa

 9.6.1 Key Trends

 9.6.2 Tremfya Market Size & Forecast, By Indication, 2022–2035

 9.6.3 Tremfya Market Size & Forecast, By Route of Administration, 2022–2035

 9.6.4 Tremfya Market Size & Forecast, By Distribution Channel, 2022–2035

 9.6.5 Tremfya Market Size & Forecast, By End User, 2022–2035

 9.6.6 Tremfya Market Size & Forecast, By Country, 2022–2035

  9.6.6.1 UAE

  9.6.6.2 Saudi Arabia

  9.6.6.3 Qatar

  9.6.6.4 South Africa

  9.6.6.5 Rest of Middle East & Africa

10. Competitive Landscape

 10.1 Key Players' Positioning

 10.2 Competitive Developments

  10.2.1 Key Strategies Adopted (%), By Key Players, 2025

  10.2.2 Year-Wise Strategies & Development, 2022–2025

  10.2.3 Number Of Strategies Adopted By Key Players, 2025

 10.3 Market Share Analysis, 2025

 10.4 Indication/Service & Route of Administration Benchmarking

  10.4.1 Indication/Service Specifications & Features By Key Players

  10.4.2 Indication/Service Heatmap By Key Players

  10.4.3 Route of Administration Heatmap By Key Players

 10.5 Industry Start-Up & Innovation Landscape

10.6 Key Company Profiles

 10.6.1 Johnson & Johnson Services, Inc.

  10.6.1.1 Company Overview & Snapshot

  10.6.1.2 Indication/Service Portfolio

  10.6.1.3 Key Company Financials

  10.6.1.4 SWOT Analysis

 10.6.2 AbbVie Inc.

10.6.3 Novartis AG

10.6.4 Eli Lilly and Company

10.6.5 UCB S.A.

10.6.6 Amgen Inc.

10.6.7 Bristol Myers Squibb Company

10.6.8 Sun Pharmaceutical Industries Ltd.

10.6.9 Biocon Biologics Limited

10.6.10 MorphoSys AG

10.6.11 Boehringer Ingelheim International GmbH

10.6.12 Pfizer Inc.

10.6.13 Takeda Pharmaceutical Company Limited

10.6.14 Genentech, Inc.

10.6.15 Regeneron Pharmaceuticals, Inc.

10.6.16 Sanofi S.A.

10.6.17 GlaxoSmithKline plc

10.6.18 Merck & Co., Inc.

10.6.19 Celltrion, Inc.

10.6.20 Samsung Bioepis Co., Ltd.

11. Analyst Recommendations

 11.1 SNS Insider Opportunity Map

 11.2 Industry Low-Hanging Fruit Assessment

 11.3 Market Entry & Growth Strategy

 11.4 Analyst Viewpoint & Suggestions on Market Growth

12. Assumptions

13. Disclaimer

14. Appendix

 14.1 List Of Tables

 14.2 List Of Figures